Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01246466 · ClinicalTrials.gov registry record · NA
Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study
A NA study, sponsored by AtriCure.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01246466: Completed NA study, sponsored by AtriCure.
NCT01246466 is a NA study that has completed, run by AtriCure. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01246466, a NA study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this clinical investigation is to evaluate how safe a less invasive cardiac surgery is using the AtriCure Bipolar System combined with a catheter ablation procedure in treating AF, and how effective this combined procedure is using the AtriCure System in treating AF. The AtriCure Bipolar System will be used to perform the less invasive cardiac surgery and a standard electrophysiology catheter, currently available, will be used to perform the catheter ablation procedure. This surgical procedure is considered less invasive because it is done through tiny surgical punctures on the sides of the chest near the ribs instead of one large surgical incision of the breast bone to completely open the chest and access the heart, and it also avoids the need for the heart-lung bypass machine.
Primary Outcome
Acute MAE within 30 days post procedure or hospital discharge (up to 7 days), whichever is longer.
Interventions
- DEVICE Hybrid: AtriCure Bipolar System & EP ablation procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-12 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT01246466 record still lists
NCT01246466 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Hybrid: AtriCure Bipolar System & EP ablation procedure is the first listed.
NCT01246466 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01246466 about?
NCT01246466 is a clinical study titled "Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study". The purpose of this clinical investigation is to evaluate how safe a less invasive cardiac surgery is using the AtriCure Bipolar System combined with a catheter ablation procedure in treating AF, and how effective this combined procedure is using the AtriCure System in treating AF. The AtriCure Bipo...
What is the current status of trial NCT01246466?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2010-12. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01246466?
The interventions under investigation include: Hybrid: AtriCure Bipolar System & EP ablation procedure (DEVICE).
Who is sponsoring clinical trial NCT01246466?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01246466's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia